Five Prime Therapeutics and Zai Lab Dosed First Patient in Phase 3, Global Registrational Trial of Bemarituzumab in Front-Line Advanced Gastric and Gastroesophageal Junction Cancers Life Science
Adlai Nortye Opens New US Headquarters, Solidifying its Position in the Global Pharma Industry Life Science
Agilent to Expand Portfolio and Capabilities in Cell Analysis with Acquisition of ACEA Biosciences Life Science
Aphria closes deal, now worth up to $300 million, to acquire Scythian’s Latin American assets Cannabis, Life Science